Christina Farr is the editor-in-chief/CEO of Second Opinion, and a GP at early-stage healthcare fund Scrub Capital.
Plus, four questions with MIDI founder Joanna Strober
We're covering healthcare's biggest ideas with the people building them.
This shiny new object is just that.
What’s Next for Lifers
Experts inside and outside the government tell us what they think..
Lawmakers have to approve a new law, which is mixed on how much taxpayers should foot the bill for healthy foods, while food manufacturers are revising their strategies for the weight-loss drug era.
Generate revenue, not just headlines
Rising compute costs have biotech firms rethinking how they use large language models.
We’re about to enter into an era of minimal funding, then exit
From fertility and menopause to sleep and recovery, Oura is building one of the largest consumer health datasets focused on women.
Plus: updates on the Ebola outbreak, CMS' prior authorization program, and Healthcare.gov
Here’s what employers are likely to do about it...
Plus all the most important news of the week!
Our next premium webinar is a Q&A with veteran payer CEO Don Antonucci
It's called SOS.
This is the model proven by Grow Therapy, now valued at $3B
Second Opinion partnered with Confido to determine which companies should make the cut.
There's a lot more of them than we expected!
We are entering into the era of Navigation 2.0.
AI, your news of the week, and an invitation ?
“We have a truth-telling problem in US healthcare.”
The biggest deals and news of the week, plus an interview with Embold Health president and founder Daniel Stein
